|
NCOA5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.77475828372553E-15 |
| Normal-vs-Stage2 |
8.9774000000542E-07 |
| Normal-vs-Stage3 |
6.43929354282591E-15 |
| Normal-vs-Stage4 |
1.62803104331033E-12 |
| Stage1-vs-Stage2 |
1.689640E-01 |
| Stage1-vs-Stage3 |
6.878400E-02 |
| Stage1-vs-Stage4 |
7.163500E-04 |
| Stage2-vs-Stage3 |
2.010100E-02 |
| Stage2-vs-Stage4 |
8.226400E-04 |
| Stage3-vs-Stage4 |
8.377600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33066907387547E-16 |
| Normal-vs-AfricanAmerican |
8.43470000511104E-08 |
| Normal-vs-Asian |
2.12359999585132E-08 |
| Caucasian-vs-AfricanAmerican |
8.295800E-01 |
| Caucasian-vs-Asian |
1.692990E-01 |
| AfricanAmerican-vs-Asian |
2.866200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.23074900165921E-14 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
8.401400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62492241884138E-12 |
| Normal-vs-Age(41-60Yrs) |
8.99280649946377E-15 |
| Normal-vs-Age(61-80Yrs) |
1.69897429458388E-12 |
| Normal-vs-Age(81-100Yrs) |
7.76530000000664E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.736800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.234200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.993200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.147200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.681400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.379400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.95140000053473E-07 |
| Classical-VS-Follicular |
7.477800E-01 |
| Classical-VS-Other |
6.439400E-01 |
| Classical-VS-Normal |
1.63336011382853E-12 |
| Tall-VS-Follicular |
3.89769999997736E-06 |
| Tall-VS-Other |
3.133800E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
6.134200E-01 |
| Follicular-VS-Normal |
7.01479985210085E-10 |
| Other-VS-Normal |
3.370100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63025148935958E-12 |
| Normal-vs-N1 |
5.88418203051333E-15 |
| N0-vs-N1 |
2.558200E-03 |
|
|
